Risers and Fallers

FTSE 100 movers: AstraZeneca slides on drug trial results; miners rally

By Michele Maatouk

Date: Thursday 09 Jul 2026

(Sharecast News) - London's FTSE 100 was down 0.2% at 10,473.04 in afternoon trade on Thursday.
AstraZeneca tumbled as it said a trial for a treatment for a rare type of heart disease had failed to meet its primary objective.

BP and Shell were both as oil prices eased back.

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page